Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Generalized Pustular Psoriasis (GPP)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07270003
What this trial is testing

A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
Xijing Hospital 60
Large-scale testing (Phase 3)Ended earlyNCT05366855
What this trial is testing

Study to Evaluate the Long-Term Safety and Efficacy of Imsidolimab (ANB019) in the Treatment of Subjects With GPP

Who this might be right for
Generalized Pustular Psoriasis
Vanda Pharmaceuticals 42
Early research (Phase 1)Active Not RecruitingNCT06433531
What this trial is testing

A Clinical Study of TQH2929 Injection in Treatment With Generalized Pustular Psoriasis (GPP)

Who this might be right for
Generalized Pustular Psoriasis
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 9
Large-scale testing (Phase 3)Study completedNCT05352893
What this trial is testing

Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With GPP

Who this might be right for
Generalized Pustular Psoriasis
Vanda Pharmaceuticals 45
Testing effectiveness (Phase 2)Looking for participantsNCT06231381
What this trial is testing

Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP)

Who this might be right for
Generalized Pustular Psoriasis (GPP)
Shanghai Huaota Biopharmaceutical Co., Ltd. 33
Testing effectiveness (Phase 2)Study completedNCT03782792
What this trial is testing

Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis

Who this might be right for
Generalized Pustular Psoriasis
Boehringer Ingelheim 53
Large-scale testing (Phase 3)Study completedNCT03051217
What this trial is testing

Test the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chronic Psoriasis

Who this might be right for
Moderate to Severe PsoriasisGeneralized Pustular Psoriasis and Erythrodermic Psoriasis
UCB Biopharma S.P.R.L. 127
Not applicableStudy completedNCT06391996
What this trial is testing

Biologic Therapy for Generalized Pustular Psoriasis

Who this might be right for
Generalized Pustular Psoriasis
Chao Ji 65
Post-approval studies (Phase 4)Looking for participantsNCT07503652
What this trial is testing

Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
First Hospital of China Medical University 10
Testing effectiveness (Phase 2)Study completedNCT04015518
What this trial is testing

Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
Boehringer Ingelheim 152
Not applicableLooking for participantsNCT05994976
What this trial is testing

Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers

Who this might be right for
AcneAtopic DermatitisChronic Hand Eczema+3 more
Innovaderm Research Inc. 500
Large-scale testing (Phase 3)Study completedNCT06323356
What this trial is testing

TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis

Who this might be right for
Generalized Pustular PsoriasisErythrodermic Psoriasis
Takeda 18
Testing effectiveness (Phase 2)Study completedNCT01845987
What this trial is testing

The Efficacy, Safety and Tolerability of CNTO 1959, a Human Anti-IL 23 Monoclonal Antibody in Participants With Palmoplantar Pustulosis

Who this might be right for
Palmoplantaris Pustulosis
Janssen Pharmaceutical K.K. 49
Not applicableLooking for participantsNCT04359394
What this trial is testing

International Rare And Severe Psoriasis Expert Network

Who this might be right for
Pustular Psoriasis (PP)
University Hospital, Basel, Switzerland 180
Not applicableStudy completedNCT05670821
What this trial is testing

PMS of Spesolimab I.V. in GPP Patients With Acute Symptoms

Who this might be right for
Generalized Pustular Psoriasis
Boehringer Ingelheim 52
Testing effectiveness (Phase 2)Ended earlyNCT01197989
What this trial is testing

Efficacy Study of TEPSO® Socks in Improving Palmoplantar Pustulosis

Who this might be right for
Pustulosis of Palms and Soles
Lenzi Egisto S.P.A. 17
Testing effectiveness (Phase 2)Looking for participantsNCT07013201
What this trial is testing

A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
LEO Pharma 135
Large-scale testing (Phase 3)Study completedNCT05239039
What this trial is testing

An Expanded Access Program in China to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment Options

Who this might be right for
Generalized Pustular Psoriasis
Boehringer Ingelheim 39
Large-scale testing (Phase 3)Study completedNCT05174065
What this trial is testing

Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)

Who this might be right for
Palmoplantar Pustulosis
Amgen 176
Large-scale testing (Phase 3)Study completedNCT02343744
What this trial is testing

An Efficacy and Safety Study of CNTO1959 (Guselkumab) in the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis

Who this might be right for
Pustular Psoriasis
Janssen Pharmaceutical K.K. 21
Next Page